BioStock: Alligator Bioscience’s Q3 is out – comments from the CEO

Swedish Alligator Bioscience recently published its report for the third quarter – a period with significant progress in its pipeline projects. BioStock talked to CEO Søren Bregenholt to learn more about reached milestones, the latest developments and his expectations for the near term.

Read the interview with Alligator Bioscience's CEO Søren Bregenholt at biostock.se:

https://www.biostock.se/2022/10/alligator-biosciences-q3-is-out-comments-from-the-ceo/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/